IP Library Granted Patent US 9,920,340
Granted Patent B2
US 9,920,340 · App. 14/608,847 · Granted Mar 20, 2018

Acyl-ACP thioesterase genes and uses therefor

Inventors: Paul Gordon Roessler (San Diego, CA); Gena Roy (San Diego, CA)
Assignee: Synthetic Genomics, Inc.
C12P7/6409C12N9/16C12N15/8247C12P7/6436C12P7/6463C12Y301/02014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,920,340
App. No.
14/608,847
Granted
Mar 20, 2018
Kind
B2
Abstract

The present invention provides novel genes encoding Class II acyl-ACP thioesterases and variants thereof that are active on C8, C10, C12, C14, C16, and C18 acyl-ACP substrates. The thioesterases can be introduced into transgenic organisms, including microorganisms and photosynthetic organisms, for producing fatty acids and fatty acid products.

Claims (31)

1. A transgenic organism comprising an exogenous nucleic acid molecule encoding a Class II acyl-ACP thioesterase comprising an amino acid sequence selected from the group consisting of an amino acid sequence having at least 90% identity to amino acid 64 to amino acid 361 of SEQ ID NO:51; the amino acid sequence of amino acid 66 to amino acid 362 of SEQ ID NO:55; an amino acid sequence having at least 96% identity to amino acid 65 to amino acid 356 of SEQ ID NO:69; and the amino acid sequence of amino acid 65 to amino acid 362 of SEQ ID NO:85.

2. A transgenic organism according to claim 1 , wherein the acyl-ACP thioesterase has a C12, C14, and/or C16 acyl substrate preference.

3. A transgenic organism according to claim 1 , wherein the transgenic organism further comprises at least one exogenous nucleic acid molecule encoding an acetyl-CoA carboxylase, a ketoacyl-CoA synthase, a fatty acid elongase, an acyl-CoA synthetase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, an alcohol acetyl transferase, an acyl-CoA alcohol transacylase, an acyltransferase, a wax synthase, an aldehyde decarbonylase, or a fatty acid decarboxylase.

4. A transgenic organism according to claim 1 , wherein the organism is plant.

5. A transgenic organism according to claim 1 , wherein the organism is a microorganism.

6. A transgenic organism according to claim 5 , wherein the organism is a photosynthetic microorganism.

7. A transgenic organism according to claim 6 , wherein the photosynthetic microorganism is a eukaryotic alga.

8. A transgenic organism according to claim 6 , wherein the photosynthetic microorganism is a cyanobacterium.

9. A method of making a fatty acid product, comprising:

culturing a transgenic microorganism according to claim 5 ; and

isolating a fatty acid product from the organism or culture medium.

10. The method of claim 9 , wherein the fatty acid product is a free fatty acid.

11. The method of claim 9 , wherein the fatty acid product comprises one or more triglycerides, fatty aldehydes, fatty alcohols, fatty esters, hydrocarbons, or fatty acids.

12. The method of claim 9 , wherein the microorganism is a photosynthetic microorganism.

13. The method of claim 12 , wherein the microorganism is cultured mixotrophically.

14. The method of claim 12 , wherein the microorganism is cultured phototrophically.

15. The method of claim 12 , wherein the photosynthetic organism is a eukaryotic alga.

16. The method of claim 12 , wherein the photosynthetic organism is a cyanobacterium.

17. The method of claim 9 , wherein at least 50% of the fatty products isolated from the organism, the culture medium, or both are C12 fatty acid products, C14 fatty acid products, C16 fatty acid products, or a combination thereof.

18. The method of claim 9 , wherein at least 20% of the fatty products isolated from the organism, the culture medium, or both are C14 fatty acid products.

19. A vector comprising a recombinant nucleic acid molecule encoding a Class II acyl-ACP thioesterase comprising an amino acid sequence selected from the group consisting of:

a) an amino acid sequence having at least 90% identity to amino acid 64 to amino acid 361 of SEQ ID NO:51;

b) the amino acid sequence of amino acid 66 to amino acid 362 of SEQ ID NO:55;

c) an amino acid sequence having at least 96% identity to amino acid 65 to amino acid 356 of SEQ ID NO:69; and

d) the amino acid sequence of amino acid 65 to amino acid 362 of SEQ ID NO:85;

wherein the vector further comprises a selectable marker.

20. A vector according to claim 19 , encoding a Class II acyl-ACP thioesterase comprising a nucleic acid sequence encoding a thioesterase that comprises an amino acid sequence selected from the group consisting of:

an amino acid sequence having at least 90% identity to SEQ ID NO:51;

the amino acid sequence of SEQ ID NO:55;

an amino acid sequence having at least 96% identity to SEQ ID NO:69; and

the amino acid sequence of SEQ ID NO:85.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
Continuity (4)
Continuation 12826592 · Jun 29, 2010
Provisional Application 61223328 · Jul 6, 2009
Provisional Application 61221500 · Jun 29, 2009
Related Publication 20150147790A1 · May 28, 2015